Back to Agenda
Risk Communication: New Directions for the Future
Session Chair(s)
Amelia Cupelli, MPharm
Senior Pharmacovigilance Assessor, PRAC member
AIFA, Italy
Risk communication is an integral component of public health management and need to be continuously updated to meet new and developing demands. When deployed effectively, risk communication is an invaluable tool for engendering trust, protecting organizational value, and helping the public make informed decisions. Conducting risk perception research, addressing the role of trust and having a realistic outlook on the impact of risk communications are crucial considerations in risk communication evolvements for the future. This session aims at discussing implications, insights and key lessons learned from the application of risk communication principles in real-world settings, offering suggestions for risk communication research, policies and strategies.
Learning Objective : Discuss the current regulatory landscape related to benefit-risk assessment and communication Share real world experiences from case-studies and the regulatory feedback from involving patients in current practice regarding benefit-risk communication
Speaker(s)
Benefit-Risk Communication: Lessons from Patients
Dinah Duarte, MSc
European Medicines Agency, Netherlands
Signal Management Lead
Evaluation of the Impact of Risk Communication on Public’s Risk Perceptions Knowledge, Attitudes, and Behaviors including Compliance (Focus groups, Surveys, and other Experiences)
Peter Mol, PharmD, PhD
MEB, Netherlands
CHMP member, NL
Risk Communication in the European Context, Building on the Best Practice Examples - Lessons from SCOPE Project
Sieta de Vries, PhD
University Medical Center Groningen, Netherlands
Post-doctoral researcher
Have an account?